Mason Lu

558 total citations
8 papers, 425 citations indexed

About

Mason Lu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Mason Lu has authored 8 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Immunology. Recurrent topics in Mason Lu's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Kruppel-like factors research (1 paper). Mason Lu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Kruppel-like factors research (1 paper). Mason Lu collaborates with scholars based in United States, United Kingdom and China. Mason Lu's co-authors include Michael S. Neuberger, Cristina Rada, Silvestro G. Conticello, Karuna Ganesh, Kanmin Xue, Sarah L. Davies, Wolf Reik, Ian N. Watt, Stephen C. Blacklow and Wendy R. Gordon and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Cell and PLoS ONE.

In The Last Decade

Mason Lu

8 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mason Lu United States 7 290 125 66 55 40 8 425
Luisa Robbez‐Masson United Kingdom 7 326 1.1× 73 0.6× 45 0.7× 56 1.0× 22 0.6× 7 421
Sachi Tsunemi Japan 8 168 0.6× 167 1.3× 42 0.6× 42 0.8× 80 2.0× 10 357
Tara M. Young United States 9 215 0.7× 62 0.5× 94 1.4× 55 1.0× 58 1.4× 10 350
Emily N. Pawlak Canada 8 137 0.5× 118 0.9× 32 0.5× 47 0.9× 100 2.5× 11 340
Susumu Kagawa Japan 7 325 1.1× 174 1.4× 138 2.1× 72 1.3× 55 1.4× 11 471
John P. Maufort United States 8 271 0.9× 100 0.8× 88 1.3× 119 2.2× 14 0.3× 12 487
Akihiro Minami Japan 12 179 0.6× 77 0.6× 54 0.8× 52 0.9× 16 0.4× 21 331
Erik W. Martin United States 11 124 0.4× 86 0.7× 37 0.6× 36 0.7× 20 0.5× 16 323
Caryll Waugh Australia 11 299 1.0× 274 2.2× 171 2.6× 28 0.5× 53 1.3× 12 628
T Liu China 4 137 0.5× 146 1.2× 63 1.0× 197 3.6× 23 0.6× 8 398

Countries citing papers authored by Mason Lu

Since Specialization
Citations

This map shows the geographic impact of Mason Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mason Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mason Lu more than expected).

Fields of papers citing papers by Mason Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mason Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mason Lu. The network helps show where Mason Lu may publish in the future.

Co-authorship network of co-authors of Mason Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Mason Lu. A scholar is included among the top collaborators of Mason Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mason Lu. Mason Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Feng, Runhua, Yuling Wang, Vijaya Ramachandran, et al.. (2020). Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3 developed against MUC18 in metastatic melanoma. Journal of Experimental & Clinical Cancer Research. 39(1). 273–273. 6 indexed citations
2.
Miao, Ping, Ping Wang, Rong Zhao, et al.. (2018). Regulatory effect of anti-gp130 functional mAb on IL-6 mediated RANKL and Wnt5a expression through JAK-STAT3 signaling pathway in FLS. Oncotarget. 9(29). 20366–20376. 17 indexed citations
3.
Zhou, Liran, Todd T. Moore, Mason Lu, et al.. (2018). Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Science Translational Medicine. 10(464). 31 indexed citations
4.
Li, Ming, Jianpeng Gao, Runhua Feng, et al.. (2013). Generation of Monoclonal Antibody MS17-57 Targeting Secreted Alkaline Phosphatase Ectopically Expressed on the Surface of Gastrointestinal Cancer Cells. PLoS ONE. 8(10). e77398–e77398. 5 indexed citations
5.
Conticello, Silvestro G., Karuna Ganesh, Kanmin Xue, et al.. (2008). Interaction between Antibody-Diversification Enzyme AID and Spliceosome-Associated Factor CTNNBL1. Molecular Cell. 31(4). 474–484. 110 indexed citations
6.
Li, Kang, Yucheng Li, Wenjuan Wu, et al.. (2008). Modulation of Notch Signaling by Antibodies Specific for the Extracellular Negative Regulatory Region of NOTCH3. Journal of Biological Chemistry. 283(12). 8046–8054. 149 indexed citations
7.
Watt, Ian N., Mason Lu, Wolf Reik, et al.. (2005). Mice Deficient in APOBEC2 and APOBEC3. Molecular and Cellular Biology. 25(16). 7270–7277. 95 indexed citations
8.
Eichstaedt, Harald C., et al.. (2004). Anesthetic Induction With Ketamine Inhibits Platelet Activation Before, During, and After Cardiopulmonary Bypass in Baboons. Artificial Organs. 28(10). 959–962. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026